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Aims: Characteristics of nephrotic syndrome (NS) in children varies in different   geographical 
areas based on genetic and environmental factors. The aim of this study is to evaluate the 
steroid response pattern and outcome of idiopathic NS (INS) in a pediatric referral hospital in 
northwest Iran.
Methods: Medical records of all admitted children under 14 years of age with INS in 
the   Children’s Hospital of Tabriz, Iran, from 1999 to 2010 were studied retrospectively. 
  Demographics, pattern of response to medications, recurrence rate, histopathology, and outcome 
were documented.
Results: A total of 165 patients with INS, with a mean age of 4.98 ± 2.61 years were studied. 
Male to female ratio was 2:1. Duration of follow-up was 5.36 ± 2.2 years (1–10 years). A total 
of 124 patients (75.2%) responded to steroids, and 41 patients (24.8%) were steroid resistant. 
Frequency of hematuria (P = 0.01) and steroid resistance (P = 0.005) in girls was significantly 
higher than boys. Patients with steroid resistance had a higher frequency of hematuria (P = 0.001) 
and a higher mean age (P = 0.017) in comparison with steroid responders. Renal biopsy carried 
out in 49 patients (29.7%) revealed minimal change in NS in 20 (40.8%), focal segmental glom-
erulosclerosis in 16 (32.7%), and mesangial proliferation in 11 (22.5%) patients. Twenty-two 
steroid resistant patients (13%) achieved remission with other immunosupressives. Nineteen 
patients (11.5%) were resistant to all treatment modalities; of these, nine (5.4%) progressed 
to end-stage renal disease, and 10 (6%) continued nephrotic range proteinuria. Seven patients 
(4.2%) died. Of the 146 patients who achieved remission with any one of the treatment modali-
ties, 91 patients (62.3%) experienced at least one recurrence episode, 15 patients (10.3%) were 
frequent relapsers, and 12 patients (8.2%) were steroid dependent. Higher age at onset of NS 
was associated with lower relapse rate (P = 0.04).
Conclusion: Demographics, histological features, and outcome of INS in our area were 
similar to western countries. In the present study, risk of steroid resistance was higher in girls 
than boys.
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Introduction
The incidence of nephrotic syndrome (NS) is estimated to be 2–7 cases per 100 000 
children per year,1–4 and its cumulative prevalence rate is 16 per 100 000 children below 
age of 16.2 NS is 15 times more common in children than adults.1   Approximately 90% 
of children with NS have idiopathic NS (INS), and the remaining 10% have   secondary 
NS, related to infections, systemic diseases, malignancy, and other glomerular diseases. 
Minimal change nephrotic syndrome (MCNS) accounts for 85% of INS, and more 
than 95% of these respond to steroid therapy and don’t need renal biopsy.1,2 Children Therapeutics and Clinical Risk Management 2011:7 submit your manuscript | www.dovepress.com
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with steroid-sensitive NS (SSNS), have a benign prognosis 
with good preservation of long-term kidney function.   Steroid 
resistance is associated with a high risk of developing chronic 
kidney disease. Focal segmental glomerulosclerosis (FSGS) 
is the main cause of steroid resistant NS (SRNS)5 and 
accounts for 10%–20% of end-stage renal disease (ESRD) in 
children.6 Previous studies emphasize the considerable influ-
ence of racial and geographical factors on steroid response 
and histological pattern and outcome of INS.7 Moreover, there 
are some reports indicating the changing face of childhood 
INS with time.8,9 Recent studies show that the frequency of 
FSGS in children has dramatically increased over the past 
two decades in some parts of world.9–11 There are few data 
about the characteristics of INS in our area. The aim of this 
study is to evaluate the steroid response pattern and long-
term outcome of pediatric INS in a tertiary care hospital in 
northwest Iran and compare it with other studies.
Materials and methods
Medical records of all admitted children under 14 years of age 
with NS in the Children’s Hospital of Tabriz, Iran, from 1999 
to 2010 were studied retrospectively. The   Children’s Hospital 
of Tabriz is the largest pediatric referral center in northwest 
Iran, and most nephrotic children are referred to this hospital. 
NS was defined as a constellation of proteinuria more than 
40 mg/m2/day, hypoalbuminemia (serum albumin , 2.5 g/dL), 
hyperlipidemia (serum cholesterol . 250 mg/dL), and edema. 
INS was defined as NS in children between 6 months and 
14 years without a systemic illness causing NS, with nor-
mal creatinine, C3, and C4   levels, which either responded to 
steroids or had a histological diagnosis of INS (MCNS or 
FSGS or mesangial proliferation in renal biopsy). Patients 
with IgA nephropathy, membranoproliferative glom-
erulonephritis, membranous nephropathy, congenital NS, 
chronic renal failure, and patients with inadequate data were 
excluded. Serum urea, creatinine, cholesterol, triglyceride, 
total protein, albumin, serum electrolytes, HBsAg, serum 
complement levels of C3, C4, ANA, urine analysis, urine 
culture, 24-hour urine protein excretion, and sonography of 
kidneys were carried out in all patients at the time of first 
admission. Indications that were considered for renal biopsy 
included: resistance to steroids, gross hematuria, age less 
than 1 year and more than 11 years, low serum level of C3 
and C4, and persistent hypertension. Frequent relapsers and 
steroid-dependent patients underwent renal biopsy before 
initiation of cyclosporine. Informed consent was obtained 
from parents before renal biopsy. The biopsy specimens were 
examined by light and   immunofluorescence microscopy. 
Patients who had no indication for renal biopsy were treated 
with prednisolone 60 mg/m2/day for 4–6 weeks followed by 
prednisolone 40 mg/m2 on alternate days for a further 4 weeks. 
The prednisolone dose was then tapered and discontinued over 
the next 2–3 months. Steroid resistants, frequent relapsers, and 
steroid dependants underwent treatment with other alternative 
agents including levamisol (2–3 mg/kg/day), cyclophos-
phamide (2–3 mg/kg/day for 8–12 months), cyclosporine 
(3–6 mg/kg/day), mycophenolate mofetil (600 mg/m2 dose 
bid) and pulse methylprednisolone (30 mg/kg bolus with the 
first six doses given every other day followed by a tapering 
regimen for periods of up to 18 months). All patients were 
followed up at the out-patient service at intervals of 1 week to 
1 month by the same nephrologists. Data including: sex, age 
of NS onset, clinical and laboratory findings, results of renal 
biopsy, pattern of response to steroids and other alternative 
agents, duration of follow-up, and outcome were collected 
in designed forms.
The following definitions were considered for classifica-
tion of response pattern to steroid therapy.1,2
1.  Steroid response: complete resolution of proteinuria 
within 4–6 weeks of steroid therapy.
2.  Relapse: occurrence of 3+–4+ proteinuria plus edema.
3.  Frequent relapse: three or more relapses within 
12 months.
4.  Steroid dependence: occurrence of relapse during taper-
ing of steroid dose or within 28 days of stopping steroid 
therapy.
5.  Steroid resistance: failure to respond to prednisolone 
therapy within 6–8 weeks.
This study was approved by the ethical committee of 
Tabriz University of Medical Sciences. Statistical pack-
age for the social sciences (SPSS) version 16 was used 
for data analysis. Quantitative variables were presented as 
mean ± standard deviation. For comparison of differences 
between qualitative variables, chi-square or exact Fisher’s 
tests were used, and for comparison of quantitative variables, 
nonparametric Mann–Whitney U test was used. A P value 
less than 0.05 was considered significant.
Results
From October 1999 to October 2010, 226 patients with NS 
admitted to the Children’s Hospital of Tabriz. Fifty-two 
(23%) patients with secondary NS and nine patients with 
incomplete data were excluded from the study, and 165 
(73%) patients with diagnosis of INS were studied. The 
mean duration of follow-up period was 5.36 ± 2.2 years 
(range 1–10 years). Mean age of patients at initial   presentation Therapeutics and Clinical Risk Management 2011:7 submit your manuscript | www.dovepress.com
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was 4.98 ± 2.61 years (range 10 months–12 years), with a 
peak incidence at 3–6 years of age (Figure 1). None of the 
patients were positive for HBsAg.
Hematuria was detected in 40 (24.2%) patients. Thirty-three 
patients had microscopic hematuria (20%) and 7 (4.2%) 
patients had gross hematuria. Hypertension was found in 19 
(11.5%) patients. There were 110 boys and 55 girls (male/
female = 2). Table 1 shows the characteristics of boys in 
comparison with girls. Frequency of hematuria (P = 0.01) 
and steroid resistance (P = 0.005) in girls was significantly 
higher than boys.
A total of 124 patients (75.2%) responded to standard 
therapy with steroids, and 41 patients (24.8%) were steroid 
resistant. Patients with SRNS had a higher frequency of 
hematuria (P = 0.001) and a higher mean age (P = 0.017) 
compared with the SSNS group (Table 2). After dividing 
the patients into four age groups, we found that age of NS 
onset has a positive predictive ability in occurrence of ste-
roid resistance (odds ratio [OR] = 1.476, confidence interval 
[CI] = 1.016–2.144). So probability of steroid resistance 
increases with age of NS onset (P = 0.04).
Renal biopsy was carried out in 49 (29.7%) patients, 
including 40 patients with SRNS and nine frequent relapser 
patients. The histopathologic results were: MCNS in 20 
(40.8%), FSGS in 16 (32.7%), diffuse mesangial prolifera-
tion (DMP) in 11 (22.5%), and focal mesangial proliferation 
in two (4%) patients. Six patients with DMP which revealed 
slight IgM deposition in immunofluorescence microscopy 
diagnosed as IgM nephropathy.
A total of 10 out of 41 (24.4%) patients with SRNS 
responded to cyclophosphamide, seven (17.1%) patients 
responded to pulse therapy with methylprednisolone, and 
five (12.2%) patients achieved remission with cyclosporine. 
A total of 19 patients were resistant to all treatment modalities 
(46.3% of steroid resistants and 11.5% of total study popula-
tion); of these, nine (5.4%) progressed to ESRD (six patients 
with FSGS and three with IgM nephropathy), and 10 patients 
(6%) continued nephrotic range proteinuria.
A total of 91 out of 146 patients (62.3%) who achieved 
remission with any one of the treatment modalities experi-
enced at least one recurrence during the follow-up period. 
Fifteen patients (10.3%) were frequent relapsers, and 
12 patients (8.2%) were steroid dependent. There was not any 
significant difference in frequency of hematuria (P = 0.16), 
hypertension (P = 0.24), and male sex (P = 0.24) between 
relapser and nonrelapser patients. Probability of recurrence 
decreased with increasing age of NS onset (OR = 0.696, 
CI = 0.487–0.995, P = 0.04).
Mortality occurred in 7 (4.38%) patients (Table 1). Five 
patients died due to complications of NS (including infections 
in four patients and cerebral thrombotic event in one patient), 
and two patients with ESRD died due to heart failure.
Discussion
In the present study we reviewed the demographics, ste-
roid response pattern, and outcome of INS in children. We 
found a male/female ratio of 2:1, which is similar to earlier 
studies which show a male preponderance.1,2 In Western 
countries, SSNS is the most common type seen in children.1,2 
Response to initial steroid therapy has been reported from 
77.6% to 88.0% in various studies.4,7,8,12–14 In our study, 
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Figure 1 Age distribution of 165 patients with idiopathic nephrotic syndrome.
Table 1 Comparison of characteristics of inS between boys 
and girls
Variable Boys Girls P value Total
number (%) 110 (66.7%) 55 (33.3%) – 165 (100%)
hematuria 19 (17.3%) 21 (38.2%) P = 0.01 40 (24.2%)
hypertension 12 (10.9%) 7 (12.7%) P = 0.46 19 (11.6%)
Steroid resistance 18 (16.4%) 23 (42%) P = 0.005 41 (24.8%)
Progression to  
eSRD
4 (3.6%) 5 (9%) P = 0.14 9 (5.4%)
Mortality 1 (0.9%) 6 (10.9%) P = 0.09 7 (4.4%)
Abbreviations: eSRD, end-stage renal disease; inS, idiopathic nephrotic syndrome.
Table 2 Comparison of children with steroid-responsive and 
steroid-resistant idiopathic nephrotic syndrome
Variable Steroid sensitive Steroid resistant P value
number (%) 124 (75.2%) 41 (24.8%) –
Boys 91 (73.4%) 19 (46.3%) –
girls 33 (26.6%) 22 (53.7%) P = 0.005
hematuria 19 (17.3%) 21 (51.2%) P = 0.001
hypertension 13 (10.5%) 6 (14.6%) P = 0.3
Mean age (years) 4.6 ± 2.4 5.8 ± 3.2 P = 0.017
Mean 24-hour  
urine protein (mg)
3190.3 ± 322.34 4157.78 ± 448.86 P = 0.11Therapeutics and Clinical Risk Management 2011:7 submit your manuscript | www.dovepress.com
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75.2% of patients responded to standard steroid therapy. 
While in black children of South Africa, steroid response 
even in MCNS was less then 50%.15 Also, in Ghana steroid 
responsiveness was reported in 50% of children with INS.16 
A study by Gulati et al showed that male sex, age more than 
8 years at onset of NS, and presence of hematuria were pre-
dictors of resistance to steroids.14 Also, in our study, mean 
age and frequency of hematuria were significantly higher in 
the SRNS than the SSNS group. However, the frequency of 
girls was significantly higher than boys in the SRNS group 
compared with the SSNS group (Table 2). This finding is in 
contradiction with most previous studies, which show a male 
preponderance both in SRNS and SSNS patients.10,17,18
SRNS is a problematic disease with a poor outcome and 
a high rate of progression to ESRD. In the present study 22% 
(9/41) of patients with SRNS reached ESRD, which is similar 
to the study of Otukesh et al in Tehran, Iran, who reported 
a 26% progression to ESRD in children with SRNS.18 In a 
study by Mekahli et al, the renal survival rate after 5, 10, 
and 15 years was 75%, 58%, and 53% respectively.17 The 
lower incidence in our study may be attributed to a shorter 
follow-up period than in the Mekahli study.
Risk factors of progression to ESRD in INS are not well 
known. A study by Chang et al showed that age of beyond 
8 years at onset of NS is associated with a higher incidence 
of hypertension, hematuria, and progression to ESRD.19 
  Mekahli et al reported that an age of more than 10 years at 
NS onset was the only independent predictor of ESRD.17 
Some studies focus on histopathology, and FSGS is gener-
ally believed to carry the worst prognosis.20 FSGS accounts 
for only 10% of INS in children,1,2 but its frequency in dif-
ferent studies ranges from 7% to 42% based on different 
criteria considered for renal biopsy.7,13,17,19,21 In our study, 
FSGS accounts for 32.7% of renal biopsies, which is within 
the reported range by other studies. Frequency of ESRD 
in patients with FSGS ranges from 13%–78% in various 
studies, depending on the follow-up period.20 In the present 
study, 6 out of 20 patients with FSGS (33%) reached ESRD, 
which is in accordance with the literature. However, many 
studies indicate that steroid responsiveness is more accurate 
in predicting outcome than histopathological diagnosis.4,22,23 
Otukesh et al found that achievement of complete or partial 
remission with any immunosuppressive drug reduces the risk 
of ESRD.18 In our study, not one of the patients who achieved 
remission with any one of the treatment modalities progressed 
to ESRD, and all patients who reached ESRD were resistant 
to all kinds of treatment modalities.
Childhood INS is characterized by a relapsing course. 
Rate of relapse has been reported from 60.5% to 84.0% 
in previous studies.3,4,7,12,22 We found a relapse rate of 62% 
in our patients, which is in accordance with the literature. 
The frequency of relapse has been noted to be higher at a 
younger age (less than 3–4 years) at onset of NS.16 The pres-
ent study also showed that the rate of recurrence decreased 
with increasing age of NS onset (P = 0.04). A study by 
Noer showed that the time interval between early steroid 
response and the first relapse, number of relapses within the 
first 6 months, hematuria, and male sex were the significant 
predictors of relapse.24 However, we didn’t find any significant 
difference in frequency of hematuria and male sex between 
relapsers and nonrelapsers.
Mortality of NS has dramatically diminished in recent 
years with the introduction of effective therapies. The over-
all mortality has been reported at 2.2%–3.1%.12,15 However, 
mortality of our patients seems to be higher than the literature, 
which may be explained by poor compliance of our patients 
or limited facilities to prevent infections.
Conclusion
Sex and age distribution, histological features, steroid response 
pattern, and outcome of INS in our study were in accordance 
with Western countries and Turkey. In this study, higher age 
at onset of NS and hematuria were found to be a risk factor for 
steroid resistance, and lower age at onset of NS increased the 
risk of recurrence. Also, our study showed a higher frequency 
of steroid resistance in girls than boys. Although the frequency 
of progression to ESRD and mortality in girls was higher than 
boys, it was not statistically significant. These findings should 
be evaluated by other multicenter investigations.
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